|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM345888510 |
| 003 |
DE-627 |
| 005 |
20250303192624.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1155/2022/8057854
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1152.xml
|
| 035 |
|
|
|a (DE-627)NLM345888510
|
| 035 |
|
|
|a (NLM)36071748
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Liu, Jie
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 09.09.2022
|
| 500 |
|
|
|a Date Revised 21.09.2022
|
| 500 |
|
|
|a published: Electronic-eCollection
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2022 Jie Liu et al.
|
| 520 |
|
|
|a Chronic pain is an enormous modern public health problem, with significant numbers of people debilitated by chronic pain from a variety of etiologies. Translocator protein 18 kDa (TSPO) was discovered in 1977 as a peripheral benzodiazepine receptor. It is a five transmembrane domain protein, mainly localized in the outer mitochondrial membrane. Recent and increasing studies have found changes in TSPO and its ligands in various chronic pain models. Reversing their expressions has been shown to alleviate chronic pain in these models, illustrating the effects of TSPO and its ligands. Herein, we review recent evidence and the mechanisms of TSPO in the development of chronic pain associated with peripheral nerve injury, spinal cord injury, cancer, and inflammatory responses. The cumulative evidence indicates that TSPO-based therapy may become an alternative strategy for treating chronic pain
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Carrier Proteins
|2 NLM
|
| 650 |
|
7 |
|a Ligands
|2 NLM
|
| 650 |
|
7 |
|a Receptors, GABA
|2 NLM
|
| 650 |
|
7 |
|a TSPO protein, human
|2 NLM
|
| 700 |
1 |
|
|a Huang, Jingyao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Zhenjiang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Rui
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Zhihao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Yongxin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ma, Baoyu
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Neural plasticity
|d 1998
|g 2022(2022) vom: 30., Seite 8057854
|w (DE-627)NLM098558390
|x 1687-5443
|7 nnas
|
| 773 |
1 |
8 |
|g volume:2022
|g year:2022
|g day:30
|g pages:8057854
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1155/2022/8057854
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2022
|j 2022
|b 30
|h 8057854
|